Rationale for Targeting VEGF, FGF, and PDGF for the Treatment of NSCLC

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s18155
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Lens Differentiation Is Controlled by the Balance Between PDGF and FGF Signaling

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2019English

Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2013English

DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk During Anti-HCV Treatment

PLoS ONE
Multidisciplinary
2016English

Rationale for Regenerative Treatment in Neonatology

Klinische Padiatrie
MedicineChild HealthPediatricsPerinatology
2012English

FGF Receptors Are Required for Proper Axonal Branch Targeting in Drosophila

Molecular Brain
Molecular NeuroscienceMolecular BiologyCellular
2019English

Angiogenic Factors (VEGF, FGF and IGF) in the Bovine Corpus Luteum

Journal of Reproduction and Development
Animal ScienceZoology
2002English

SERUM LEVELS OF HEMOPOIETIC AND ANGIOGENESIS GROWTH FACTORS (IL-5, IL-7, IL-9, FGF-β, G-Csf, VEGF AND PDGF) IN WOMEN WITH UTERINE MYOMA

Medical Immunology (Russia)
AllergyImmunology
2018English

Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2017English

Rationale for Targeting BCL6 in MLL-rearranged Acute Lymphoblastic Leukemia

Genes and Development
GeneticsDevelopmental Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy